InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Wills Robert James. Officer active across 4 companies, notably Milestone Pharmaceuticals Inc.. Aggregated, 9 reports have been recorded. Split: 5 buys · 1 sell. Total volume traded: €355k. Activity tracked since 19 October 2022. The latest transaction was filed on 21 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Wills Robert James is a Director at Oncternal Therapeutics, Inc., Alpha Cognition Inc., Milestone Pharmaceuticals Inc. and CymaBay Therapeutics, Inc. He has 8 filings in total, and in the sampled recent filings the activity runs from 2022-10-21 to 2026-01-16, with EUR 264491 of buys and EUR 8184 of sells, and the most frequent transaction nature being Acquisition.